Head-to-Head: pill or therapy for Alzheimer's?
NCT ID NCT04661280
Summary
This study aims to find out which approach works better for people newly diagnosed with Alzheimer's disease: taking the medication donepezil or receiving a specialized non-drug therapy program. It will involve 240 participants in France who will be randomly assigned to one of the two treatments for 6 months. Researchers will measure changes in memory, thinking, daily function, and quality of life to see which strategy provides more benefit.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALZHEIMER DISEASE, EARLY ONSET are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
Cognitive Neurology Center
RECRUITINGParis, 75010, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.